iBio, Inc. (IBIO) vs Neonc Technologies Holdings, Inc. (NTHI)

A side-by-side comparison of iBio, Inc. and Neonc Technologies Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IBIO vs NTHI

growth of $100 · dividends reinvested · last 1y
IBIO -6.7% (-6.7%/yr)NTHI -69.7% (-69.7%/yr)IBIO compounded faster over this window
50100150200250Start $1002026$93$30
IBIO NTHI

IBIO vs NTHI: by the numbers

  • •NTHI is the larger company ($76M vs $67M market cap).
  • •Both run net losses; IBIO's is the smaller (-33044.00% vs -155404.38% net margin).

Metrics side by side

Valuation

MetricIBIONTHI
P/S ratio672.01N/A
P/B ratio0.78N/A

Profitability

MetricIBIONTHI
Gross margin100.00%100.00%
Operating margin-35141.00%-145459.36%
Net margin-33044.00%-155404.38%
ROE-38.55%N/A
ROIC-40.22%N/A

Growth (annualized)

MetricIBIONTHI
Revenue CAGR (5Y)-46.91%N/A
Total return CAGR (5Y)-70.43%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.